Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021: Interview Guides for MATernaL and Infant NetworK to Understand Outcomes Associated with Medication for Opioid Use Disorder during Pregnancy (MAT-LINK) Surveillance Evaluation

Details

• Alternative Title:
  Interview Guides for Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder during Pregnancy (MAT-LINK) Surveillance Evaluation
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2023; v. 72, no. 3
• Series:
  Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  1546-0738 (print) ; 1545-8636 (digital)
• Document Type:
  Text
• Pages in Document:
  7 pdf pages
• Volume:
  72
• Issue:
  3
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:558236ff85c24696ccb0ea389785c913906600ed46ff65cc8365232b2813a605952f29f750559663e3998db1af0d9e68fb85a8e5a9c29115c0034287f33020cc
• Download URL:
  https://stacks.cdc.gov/view/cdc/126231/cdc_126231_DS1.pdf
• File Type:
  [PDF - 113.85 KB ]